3 months ago
KNSA
AnalystsEva Fortea VerdejoEva Fortea Verdejo's Stock Forecasts
AnalystsEva Fortea Verdejo
Sectors:
Industries:
Analyst Ranking
Top 13%
#648 out of 5139 analysts
Average Return
+53.89%
Win Rate
86%19 out of 22
Risk vs Reward
Poor
Good
Eva Fortea Verdejo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcus Biosciences IncRCUS | +212.98% | $8.01 | $25.07 | 2025-05-06 - 2025-12-09 | Strong Buy |
Arcus Biosciences IncRCUS | +170.15% | $9.28 | $25.07 | 2025-08-06 - 2025-12-09 | Strong Buy |
Xencor IncXNCR | +129.64% | $7.32 | $16.81 | 2025-08-06 - 2025-12-09 | Strong Buy |
Merus NvMRUS | +127.08% | $41.25 | $93.67 | 2025-02-06 - 2025-09-29 | Strong Buy |
Merus NvMRUS | +119.01% | $42.77 | $93.67 | 2025-05-07 - 2025-09-29 | Strong Buy |
Eva Fortea Verdejo Analyst Color
Get additional color on Eva Fortea Verdejo's coverage of popular stocks
Eva Fortea Verdejo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | 3 | Hold | $25.00 | -3.12% | Maintains | 21 days ago |
Bicara Therapeutics IncBCAX | 3 | Hold | $11.00 | -41.24% | Maintains | a month ago |
Relay Therapeutics IncRLAY | 1 | Hold | $6.00 | -20.84% | Maintains | a month ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $60.00 | +63.76% | Initiates Coverage On | a month ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | $29.00 | +15.68% | Maintains | 2 months ago |
Merus NvMRUS | 5 | Hold | $97.00 | +0.66% | Downgrades | 2 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $45.00 | +9.38% | Maintains | 3 months ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $70.00 | -10.04% | Maintains | 3 months ago |
Iteos Therapeutics IncITOS | 7 | Hold | $11.00 | +8.37% | Maintains | 4 months ago |
Xencor IncXNCR | 3 | Strong Buy | $27.00 | +60.62% | Maintains | 4 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $44.00 | +29.11% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.